DemirtasKErtemAGAkdiATakBTEkizlerFAAkbogaMK. Status of diabetes mellitus or HbA1c levels for burden of coronary artery disease. Angiology. 2019;70(2):185.
2.
AcarBOzekeOKarakurtM. Association of prediabetes with higher coronary atherosclerotic burden among patients with first diagnosed acute coronary syndrome. Angiology. 2019;70(2):174–80.
3.
ZimmetPZ. Diabetes and its drivers: the largest epidemic in human history?Clin Diabetes Endocrinol. 2017;3:1.
4.
ChadtAScherneckSJoostHGAl-HasaniH. Molecular links between obesity and diabetes: “diabesity”. In: De GrootLJChrousosGDunganK, eds. South Dartmouth, MA: Endotext; 2000.
5.
KurlandIJAcciliDBurantC. Application of combined omics platforms toaccelerate biomedical discovery in diabesity. Ann N Y Acad Sci. 2013;1287:1–16.
6.
VermaSHussainME. Obesity and diabetes: an update. Diabetes Metabolic Syndr. 2017;11(1):73–79.
7.
LundeenEAParkSPanLO’TooleTMatthewsKBlanckHM. Obesity prevalence among adults living in metropolitan and nonmetropolitan counties—United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(23):653–58.
8.
EckelRHKahnSEFerranniniE. Obesity and type 2 diabetes: what can be unified and what needs to be individualized?Diabetes Care. 2011;34(6):1424–30.
9.
AhlqvistEStormPKarajamakiA. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6(5):361–69.
10.
RoderMEPorteDJrSchwartzRSKahnSE. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1998;83(2):604–8.
11.
DefronzoRA.Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773–95.
12.
MosesALundNJensenBNapierD. lllustrating the pivotal role of obesity as a driver of diabetes. 25th European Congress on Obesity; Vienna, Austria, May 23-26, 2018: Abstract T3P28. Obes Facts. 2018;11(suppl 1):199.
13.
OzekeOGungorMTopalogluSArasDOzerC. Chronic total artery occlusions in noninfarct-related coronary arteries. Int J Angiol. 2014;23(1):17–22.
14.
ZhangTZhangHLiY. Long-term impact of temporal sequence from childhood obesity to hyperinsulinemia on adult metabolic syndrome and diabetes: The Bogalusa Heart Study. Sci Rep. 2017;7:43422.
15.
KhanMASt PeterJVBreenGAHartleyGGVesseyJT. Diabetes disease stage predicts weight loss outcomes with long-term appetite suppressants. Obes Res. 2000;8(1):43–48.
16.
JavedAJumeanMMuradMH. Diagnostic performance of body mass index to identify obesity as defined by body adiposity in children and adolescents: a systematic review and meta-analysis. Pediatr Obes. 2015;10(3):234–44.
17.
OkoroduduDOJumeanMFMontoriVM. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes. 2010;34(5):791–99.
18.
HanSJBoykoEJ. The evidence for an obesity paradox in type 2 diabetes mellitus. Diabetes Metab J. 2018;42(3):179–187.
19.
OzekeOOzerCGungorMCelenkMKDincerHIlicinG. Chronic intermittent hypoxia caused by obstructive sleep apnea may play an important role in explaining the morbidity-mortality paradox of obesity. Med Hypotheses. 2011;76(1):61–63.
20.
DaltonMCameronAJZimmetPZ. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med. 2003;254(6):555–63.
21.
BigaardJTjonnelandAThomsenBLOvervadKHeitmannBLSorensenTI. Waist circumference, BMI, smoking, and mortality in middle-aged men and women. Obes Res. 2003;11(7):895–903.
22.
EmdinCAKheraAVNatarajanP. Genetic association of waist-to-hip ratio with cardiometabolic traits, type 2 diabetes, and coronary heart disease. JAMA. 2017;317(6):626–34.
23.
NeelandIJTurerATAyersCR. Dysfunctional adiposity and the risk of prediabetes an type 2 diabetes in obese adults. JAMA. 2012;308(11):1150–59.
24.
ElagiziAKachurSLavieCJ. An overview and update on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis. 2018;61(2):142–150.
25.
GregoryABLesterKKGregoryDMTwellsLKMidodziWKPearceNJ. The relationship between body mass index and the severity of coronary artery disease in patients referred for coronary angiography. Cardiol Res Pract. 2017;2017:5481671.
26.
KoshizakaMLopesRDNewbyLK. Obesity, diabetes, and acute coronary syndrome: differences between Asians and whites. Am J Med. 2017;130(10):1170–76.
27.
AdesPASavagePD. Obesity in coronary heart disease: an unaddressed behavioral risk factor. Preventive Med. 2017;104:117–19.
28.
PageP. Beyond statistical significance: clinical interpretation of rehabilitation research literature. Int J Sports Phys Ther. 2014;9(5):726–36.
29.
HartCLHoleDJLawlorDADavey SmithG. How many cases of type 2 diabetes mellitus are due to being overweight in middle age? Evidence from the Midspan prospective cohort studies using mention of diabetes mellitus on hospital discharge or death records. Diabet Med. 2007;24(1):73–80.
30.
KotsisVTsioufisKAntzaC. Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part B: obesity-induced cardiovascular disease, early prevention strategies and future research directions. J Hypertens. 2018;36(7):1441–55.
31.
CaspardHJabbourSHammarNFeniciPSheehanJJKosiborodM. Recent trends in the prevalence of type 2 diabetes and the association with abdominal obesity lead to growing health disparities in the USA: an analysis of the NHANES surveys from 1999 to 2014. Diabetes Obes Metab. 2018;20(3):667–71.
32.
ShiauJYSoDYFDentRR. Effects on diabetes medications, weight and glycated hemoglobin among adult patients with obesity and type 2 diabetes: 6-month observations from a full meal replacement, low-calorie diet weight management program. Can J Diabetes. 2018;42(1):56–60.
33.
KarakurtMAcarBOzekeO. Advantages and pitfalls of the glycated hemoglobin A1c measurement in acute coronary syndrome: start simple, evolve to more sophisticated. Angiology. 2019;70(2):182–4.
34.
RydénLGrantPJAnkerSD. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD–summary. Eur Heart J. 2013;34:3035–87.
35.
SchererPEHillJA. Obesity, diabetes, and cardiovascular diseases: a compendium. Circ Res. 2016;118(11):1703–5.
36.
ErtanCOzekeOGulM. Association of prediabetes with diffuse coronary narrowing and small-vessel disease. J Cardiol. 2014;63(1):29–34.
37.
DavidsonMHPlutzkyJ. The role of cardiologists in the management of patients with diabetes is evolving owing to the close relationship between diabetes and CAD. Introduction. Am J Cardiol. 2011;108(3 suppl):1B–B.
